MA46051A - Nouvelle composition améliorée de racecadotril - Google Patents

Nouvelle composition améliorée de racecadotril

Info

Publication number
MA46051A
MA46051A MA046051A MA46051A MA46051A MA 46051 A MA46051 A MA 46051A MA 046051 A MA046051 A MA 046051A MA 46051 A MA46051 A MA 46051A MA 46051 A MA46051 A MA 46051A
Authority
MA
Morocco
Prior art keywords
racecadotril
improved composition
new improved
new
composition
Prior art date
Application number
MA046051A
Other languages
English (en)
Inventor
Katarina Lindell
Salih Muhsin Muhammed
Original Assignee
Johnson & Johnson Consumer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer Inc filed Critical Johnson & Johnson Consumer Inc
Publication of MA46051A publication Critical patent/MA46051A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA046051A 2016-08-23 2017-08-21 Nouvelle composition améliorée de racecadotril MA46051A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE1651126 2016-08-23

Publications (1)

Publication Number Publication Date
MA46051A true MA46051A (fr) 2021-03-31

Family

ID=59895340

Family Applications (1)

Application Number Title Priority Date Filing Date
MA046051A MA46051A (fr) 2016-08-23 2017-08-21 Nouvelle composition améliorée de racecadotril

Country Status (5)

Country Link
US (1) US20190274964A1 (fr)
EP (1) EP3503926B1 (fr)
MA (1) MA46051A (fr)
RU (1) RU2745888C2 (fr)
WO (1) WO2018037331A1 (fr)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090312358A1 (en) * 2006-03-22 2009-12-17 Trustees Of Boston University Method for management of diarrhea
US9801819B2 (en) * 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
RU2632441C2 (ru) * 2012-06-28 2017-10-04 МакНЕЙЛ-ППС, ИНК. Липидные композиции рацекадотрила
TR201801726T4 (tr) * 2012-12-26 2018-03-21 Ilko Ilac Sanayi Veticaret A S Rasekadotri̇l ve farmasöti̇k bi̇leşi̇mleri̇.
MA40859A (fr) 2014-10-29 2017-09-05 Johnson & Johnson Consumer Inc Particules de cadotril
WO2017026994A1 (fr) 2015-08-07 2017-02-16 Johnson & Johnson Consumer Inc. Méthodes de traitement au moyen de compositions de cadotril

Also Published As

Publication number Publication date
EP3503926B1 (fr) 2023-06-07
US20190274964A1 (en) 2019-09-12
RU2745888C2 (ru) 2021-04-02
WO2018037331A1 (fr) 2018-03-01
EP3503926C0 (fr) 2023-06-07
RU2019108285A (ru) 2020-09-25
EP3503926A1 (fr) 2019-07-03
RU2019108285A3 (fr) 2020-11-03

Similar Documents

Publication Publication Date Title
DK3368014T3 (da) Nye formuleringer af cannabinoider
DK3137169T3 (da) Hæmmere af lysin-specifik demethylase-1
FR3021533B1 (fr) Composition cosmetique de type gel
DK3509581T3 (da) Formuleringer af (r)-2-amino-3-phenylpropylcarbamat
DK3180331T3 (da) Polymorfer af selinexor
DK3370949T3 (da) Sammensætning af tætningsmiddel
DK3362151T3 (da) Sammensætning indeholdende oleosomer af forskellig størrelsesfordeling
DK3524255T3 (da) Sammensætning til behandling af acne
DK3283210T3 (da) Fremgangsmåde
DK3220891T3 (da) Sublingual formulering af riluzol
DK3528902T3 (da) Ringegelsammensætning
DK3368044T3 (da) Behandling af hepatisk steatose-relateret oligo-ovulation
DK3511000T3 (da) Krystallinsk form x2 af grapiprant
DK3678644T3 (da) Formuleringer af copanlisib
DK3430004T3 (da) Faststofformer af nilotinibsalte
DK3310331T3 (da) Injicerbare farmaceutiske formuleringer af lefamulin
DK3062448T3 (da) Dæmpning af krydstale
DK3580197T3 (da) Oprensning af pleuromutilin
DK3173071T3 (da) Formularing af maropitant
DK3416502T3 (da) Glykæmisk-reducerende sammensætning
ES1137506Y (es) Helice reductora de perdidas
FI20150044A (fi) Rasvahappokoostumus
FR3025098B1 (fr) Composition cosmetique de type gel facilement demaquillable
MA43126A (fr) Compositions pharmaceutiques de fumarate de diméthyle
MA43166A (fr) Formulation de fviii